Throughout the course of its development, Nano-Cancer^® therapy has attracted a great deal of interest from the media, both in Germany and around the world. Here is some of the coverage received in the international press (for German coverage, please see the German-language version of this site or go to Nanostart.de or MagForce.com)

The Economist: "Golden slingshot": "The next generation of cancer treatments may be delivered by nanoparticles. MagForce Nanotechnologies, based in Berlin, has conducted three clinical trials of anti-cancer nanoparticles made from iron oxide and is now running another five." >>

ScienceNews: "Nanomagnets tackle cancer": "MagForce, the only group to have tested nanomagnet therapy in people, appears closest to commercialization. Over the past five years, it has conducted trials, enrolling patients with at least eight tumor types." >>

Forbes/Wolfe Emerging Tech Report: "Companies to Watch": "Targeting cancer cells was among nanotechnology’s earliest promises, and German start-up Magforce Nanotechnologies is coming close to fielding one of the first commercial treatments." >>